Bone Marrow Trephine (BMT)|
PURPOSE OF PROGRAMME:
The UK NEQAS CPT Bone Marrow Trephine (BMT) Biopsy scheme is aimed at laboratories / organisations performing BMT biopsies, as part of routine Cellular Pathology or as a stand-alone unit. BMT biopsies are carried out in a number of specialist and routine pathology centres and departments in the UK and overseas, and are an essential diagnostic tool to enable pathologists to diagnose an array of haematopathological disorders. BMT biopsies are used in the diagnosis of a number of conditions, including leukaemia, multiple myeloma, lymphoma, anaemia, and pancytopenia. The bone marrow produces the cellular elements of the blood, including platelets, red blood cells and white blood cells. While much information can be collected by testing the blood itself, it is sometimes necessary to examine the source of the blood cells in the bone marrow to obtain more information. As BMT is a specialised tissue, it is approached as such within routine laboratories, employing specialist handling. Best practice and close liaison with haematologists ensures ease of reporting to ensure correct diagnosis.
PROGRAMME OF ANALYSIS:
UK NEQAS CPT BMT Biopsy scheme assesses the proficiency of participants on archival surgical BMT biopsies using archival surgical Haematoxylin and Eosin (H&E) stained sections, and Reticulin (Retic) stained sections at each distribution, 6 distributions annually. Using an agreed annual schedule, participants who have registered with UK NEQAS CPT, receive and return to UK NEQAS CPT sections of tissue that they have tested for an agreed test item.
Details of the performance criteria for this programme can be obtained from UK NEQAS Cellular Pathology Technique (CPT) directly.
Telephone: +44 (0) 191 816 1030
Cellular Pathology Technique (CPT)
UK NEQAS CPT is an international organisation providing a comprehensive range of EQA and proficiency testing programmes for all aspects of tissue diagnostics. UK NEQAS CPT has been successfully running for over 20 years, providing a secure, established service, encompassing EQA and proficiency testing programmes, education and support for all practicing pathology laboratories in the UK and to other pathology based facilities throughout the world. Our participating laboratories have collectively submitted over 190,000 slides to our scheme, to be graded by our experts, to guide and to ensure best practice and gold standard results. We ensure that all our participants receive high quality, appropriate, clinically relevant and challenging samples that fully meet their facility’s requirements; and that our assessment of those samples is consistent, carried out by qualified assessors, graded and anonymously compared and peer reviewed. UK NEQAS CPT is a UKAS accredited proficiency testing provider No. 8268